This website uses cookies to ensure you get the best experience on our website.
Privacy Policy
I Agree
UroToday
Contact
Login
Sign Up Free
Transformative Evidence
mCRPC
The RALU Study: Treatment Considerations in the First Line Setting of mCRPC
PROfound
VISION Trial
mHSPC
ARASENS Trial
nmCRPC
ARAMIS Trial
PSMA PET Imaging
CONDOR Trial
OSPREY Trial
Bladder Cancer
Bladder Cancer Detection
Centers of Excellence
Urologic Oncology
Left Group
Health Policy
Health Policy
Ruchika Talwar, MD
Bladder Cancer
Bladder Cancer
Ashish Kamat, MD
Advanced Bladder Cancer
Petros Grivas, MD
Kidney Cancer
Advanced Kidney Cancer
Pedro Barata, MD, MSc
Kidney Cancer Today
Sumanta (Monty) Kumar Pal, MD
Jaime Landman, MD
Prostate Cancer
Advanced Prostate Cancer
Alicia Morgans, MD, MPH
CRPC with Bone Metastases
Rana R. McKay, MD
Imaging Center
Phillip Koo, MD
Localized Prostate Cancer
Matthew R. Cooperberg, MD, MPH
mHSPC
Alicia Morgans, MD, MPH
nmCRPC
Alicia Morgans, MD, MPH
PSMA-Targeted Therapy
Disparities: Social Determinates of Health
Disparities: Social Determinates of Health
Samuel L. Washington III, MD, MAS
Translational Prostate Cancer
Women in Science
Andrea Miyahira, Ph.D
Upper Tract Urothelial Carcinoma
Upper Tract Urothelial Carcinoma
Sam S. Chang, MD, MBA
TESTICULAR, PENILE & RARE GU MALIGNANCIES
Testicular, Penile, and Rare GU Malignancies
Pelvic Health & Reconstruction
Bladder Health
Diane K. Newman, DNP, ANP-BC, FAAN
Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU)
Stephen R. Kraus, MD
Urologic Catheters (Includes CAUTI)
Diane K. Newman, DNP, ANP-BC, FAAN
Videos
Exclusives
Conferences
Exclusive Collaborations
Independent Education
Covid-19
The Prostate Cancer Foundation
Urologic Oncology
Prostate Cancer
Bladder Cancer
Kidney Cancer
Upper Tract Urothelial Tumors
Pelvic Health & Reconstruction
Endourology
Testicular Cancer
Health Policy in Urological Diseases
Disparities: Social Determinates of Health
Clinical Trials
From the Editor
Search Clinical Trials
Trials in Progress
DORA - PCCTC
IRONMAN - PCCTC
PROMISE - PCCTC
SPLASH Trial
Oral EPI-7386
Articles
Urology (benign and malignant)
Urologic Oncology
Men's Health
Endourology & Stones
Pediatric Urology
COVID-19 and Genitourinary Cancers
Pelvic Health
Pelvic Health & Reconstruction
Conference Coverage
Recent Conferences
ASCO GU 2023
EAU 2023
SES AUA 2023
All Conferences
View All
PCF
UroToday Home
Recent Abstracts
Urologic Oncology
Bladder Cancer
Conferences
Recent Abstracts
#AUA15 - A mass spectrometry-based approach to identify environmental endocrine disruptors in the development of hypospadias - Session Highlights
May 16, 2015
#AUA15 - Outcomes of single stage vs. two-stage sacral neurostimulation in children with bowel and bladder dysfunction - Session Highlights
May 16, 2015
#AUA15 - Antimicrobial utilization prior to endourological surgery for urolithiasis: Endourological Society survey results - Session Highlights
May 16, 2015
#AUA15 - Impact of delaying treatment for kidney stones
May 16, 2015
#AUA15 - Workplace dangers and safety for the urologist - Session Highlights
May 16, 2015
#AUA15 - Measuring success after radical cystectomy: feasibility of a novel composite endpoint (“poor recovery”) to quantify outcomes after surgery - Session Highlights
May 16, 2015
#AUA15 - MRI-fusion prostate biopsy in first-time biopsy cohort yields increased detection of clinically significant prostate cancer using a simplified MRI grading scale - Session Highlights
May 16, 2015
#AUA15 - Predictive value of plasma soluble Met protein concentration in patients with prostate cancer - Session Highlights
May 16, 2015
#AUA15 - Multiparametric magnetic resonance imaging and MRI/ultrasound fusion-guided biopsy predicts total tumor burden confirmed by whole mount prostatectomy - Session Highlights
May 16, 2015
#AUA15 - Effect of onabotulinumtoxinA treatment for neurogenic detrusor overactivity on the prevention of autonomic dysreflexia - Session Highlights
May 16, 2015
#AUA15 - Lack of sexual health knowledge among young males
May 16, 2015
#AUA15 - Long-term efficacy and safety of onobotulinumtoxinA in patients with neurogenic detrusor overactivity: Analysis among patients who completed 4 years of treatment - Session Highlights
May 16, 2015
#AUA15 - The natural history of targeted biopsy negative lesions identified on multiparametric magnetic resonance imaging - Session Highlights
May 16, 2015
#AUA15 - Upper tract urothelial carcinoma update - Session Highlights
May 16, 2015
#AUA15 - Crossfire: Controversies in Urology: Resolved - SWL should be retired - Session Highlights
May 16, 2015
#AUA15 - Evidence demonstrates long-term efficacy of botulinum toxin A treatment for neurogenic and non-neurogenic overactive bladder - Session Highlights
May 16, 2015
#AUA15 - Studies raise questions about appropriate urinary tract infection management
May 16, 2015
#AUA15 - Slide Presentation: Clinical utility of CCP test in personalizing prostate cancer treatment
May 16, 2015
#AUA15 - Poster: Validation of an active surveillance threshold for the CCP score in conservatively managed men with localized prostate cancer
May 16, 2015
#AUA15 - Overactive bladder treatment linked to decreased fall risk for older adults
May 16, 2015
Page 438 of 507
Start
Prev
433
434
435
436
437
438
439
440
441
442
Next
End
×
Login
Login to update email address, newsletter preferences and use bookmarks.
Email
Password
Login
Forgot Password?
Sign Up Free